CVE-2026-24217
Medium
Elevated severity or exploit probability.
CVSS base
8.8
HIGH
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H
EPSS — probability of exploitation (30 days)
0.8%
53.9th percentile
CISA KEV
Not listed
Weakness / dates
CWE-29
Published 2026-05-20 · modified 2026-07-23
CVSS breakdown
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H
| Attack Vector | N | Network |
| Attack Complexity | L | Low |
| Privileges Required | N | None |
| User Interaction | R | Required |
| Scope | U | Unchanged |
| Confidentiality | H | High |
| Integrity | H | High |
| Availability | H | High |
Timeline
- 2026-05-20 — Published (NVD)
- 2026-07-23 — Last modified (NVD)
Description
NVIDIA BioNeMo Core for Linux contains a vulnerability where a user could cause a path traversal by loading a malicious file. A successful exploit of this vulnerability might lead to code execution, denial of service, information disclosure, and data tampering.